- Home
- PAYS vs STRO Comparison
PAYS vs STRO Comparison
Compare PAYS & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAYS | STRO |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | N/A | 131 |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.4M | 338.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PAYS | STRO |
|---|---|---|
| Price | $5.92 | $23.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | $9.42 | ★ $26.38 |
| AVG Volume (30 Days) | ★ 1.2M | 160.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 85.71 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $24,120,434.00 | N/A |
| Revenue This Year | $34.33 | N/A |
| Revenue Next Year | $14.64 | $13.45 |
| P/E Ratio | $45.54 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | $0.52 |
| 52 Week High | $8.88 | $27.96 |
Technical Indicators
Market Signals| Indicator | PAYS | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 81.25 | 57.93 |
| Support Level | $5.09 | $0.76 |
| Resistance Level | $8.73 | $27.96 |
| Average True Range (ATR) | 0.39 | 2.05 |
| MACD | 0.24 | -0.15 |
| Stochastic Oscillator | 94.87 | 67.80 |
Price Performance
Historical ComparisonAbout PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.